icon-folder.gif   Conference Reports for NATAP  
 
  ICAAC 2015 55th Interscience Conference
on Antimicrobial Agents and Chemotherapy
September 5-9, 2015, San Diego, CA
Back grey_arrow_rt.gif
 
 
 
Pharmacokinetics, Safety, and Tolerability of EDP-239,
a novel Hepatitis C NS5A inhibitor, in Healthy Volunteers

 
 
  Reported by Jules Levin
ICAAC 2015 Sept 17-21 2015 San Diego, CA
 
Lijuan Jiang1, Xuemin Jiang2, Kiran Dole2, Kimberly Caliri1, Kenneth Tack1, Richard Colvin2, Yat Sun Or1
1 Enanta Pharmaceuticals Inc., Watertown MA; 2 Novartis Institutes for Biomedical Research, Cambridge, MA

ICAAC1.gif

ICAAC2.gif

ICAAC3.gif

ICAAC4.gif

ICAAC5.gif

ICAAC6.gif

ICAAC7.gif

ICAAC8.gif

ICAAC9.gif